Prof. Daisuke Yabe on East-West Diabetes Research and the Future of Stem Cell Therapy for Diabetes
Watch the full video on YouTube. In this episode of Diabetes Insights, Vivienne Parry speaks with Prof. Daisuke Yabe (Kyoto University) about why EASD has become one of the world’s leading forums for diabetes research and collaboration.
The discussion explores how differences in diabetes phenotypes between Europe and East Asia are helping researchers better understand the disease, improve treatments and develop new scientific collaborations across continents.
Professor Yabe also discusses the exciting progress being made in regenerative medicine, including clinical trials using iPS cell-derived islet cells for people living with type 1 diabetes. He explains how this approach could help overcome donor shortages and bring scalable cell therapies closer to clinical practice.
Topics covered:
International collaboration in diabetes research
iPS cell-derived islet transplantation
Stem cell therapies for type 1 diabetes
Clinical trials in Japan
The future of regenerative medicine
Featured speaker:
Prof. Daisuke Yabe – Kyoto University
For more content from previous episodes, visit our podcast archive.
